GSK3A and Parkinson disease: Collectively, this work suggests that drugs such as AZD5438 that inhibit both GSK3α/β and CDKs may confer protections to cells when they are under physiological stresses associated with the aetiology of neurodegenerative diseases such as PD and AD.